Reason for request
Inclusion
Clinical Benefit
| Substantial |
Substantial actual benefit |
Clinical Added Value
| no clinical added value |
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection. |
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
zXBN9eTrDSnWNrXX
